Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Optivar
Synonyms :
azelastine ophthalmic
Class :
Antihistamines, Ophthalmic
Brand Name :
Optivar
Synonyms :
azelastine ophthalmic
Class :
Antihistamines, Ophthalmic
Dosage Forms & StrengthsÂ
ophthalmic solutionÂ
0.05%Â
Indicated for Allergic Conjunctivitis
Apply one drop into the affected eye/eyes two times a day
Dosage Forms & StrengthsÂ
ophthalmic solutionÂ
0.05%Â
Indicated for Allergic Conjunctivitis
Age >3 years
Apply one drop into the affected eye/eyes two times a day
Age <3 years
Safety and efficacy not established
Refer to adult dosingÂ
it may enhance the serum concentration when combined with azelastine
it may enhance the serum concentration when combined with azelastine
it may enhance the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
it may diminish the metabolism when combined with azelastine
Actions and Spectrum:Â
azelastine ophthalmic is an antihistamine medication commonly used to treat allergic conjunctivitis (eye allergies). It is available as eye drops and works by blocking the effects of histamine, which causes allergic symptoms in the body.Â
The action of azelastine ophthalmic involves inhibiting the release of histamine from mast cells and blocking histamine receptors in the eyes. Doing so helps reduce symptoms such as itching, redness, watering, and swelling of the eyes caused by allergic reactions.Â
Regarding its spectrum, azelastine ophthalmic primarily targets the eyes and is used to treat ocular (eye) allergies. It is not intended for systemic use or for treating nasal allergies or other allergic conditions outside the eye.Â
Frequency definedÂ
>10%Â
Transient burning or stinging (30%)Â
Bitter taste (10%)Â
Headache (15%)Â
Frequency not definedÂ
RhinitisÂ
PruritusÂ
Bitter tasteÂ
Eye painÂ
FatigueÂ
AsthmaÂ
ConjunctivitisÂ
PharyngitisÂ
Temporary blurringÂ
Influenza-like symptomsÂ
DyspneaÂ
Black Box Warning:Â
NoneÂ
Contraindication/Caution:Â
ContraindicationÂ
azelastine ophthalmic should be used with caution and under the supervision of a healthcare professional. Â
CautionÂ
Pregnancy consideration:Â Â
US FDA pregnancy category: CÂ
Lactation:  Â
Excreted into human milk: Not known.Â
Pregnancy category:Â
Pharmacology:Â
azelastine ophthalmic is an antihistamine medication with pharmacological effects by blocking the H1 histamine receptors in the eyes. It generally inhibits the release of histamine from mast cells, thereby reducing the allergic response in the ocular tissues.
By blocking histamine receptors, azelastine ophthalmic prevents the binding of histamine, which produces symptoms such as itching, redness, watering, and swelling associated with allergic conjunctivitis.
The exact mechanism of action of azelastine ophthalmic is not fully understood, but its antihistaminic properties contribute to its ability to alleviate allergic symptoms in the eyes.Â
Pharmacodynamics:Â
Mechanism of action: The action of azelastine ophthalmic involves its antihistaminic properties and its ability to block H1 histamine receptors in the eyes. It acts as a selective antagonist at these receptors, preventing the binding of histamine to the receptor sites. By blocking the H1 histamine receptors in the ocular tissues, azelastine inhibits the effects of histamine, which is released during an allergic reaction.Â
Histamine is a chemical mediator released from mast cells in response to an allergen exposure. It contributes to developing allergic symptoms in the eyes, such as itching, redness, watering, and swelling. By blocking the H1 histamine receptors, azelastine ophthalmic helps to prevent the activation of these receptors by histamine, thereby reducing the allergic response and alleviating the associated symptoms.Â
In addition to its antihistaminic effects, azelastine may exhibit some anti-inflammatory properties, further contributing to its therapeutic action in allergic conjunctivitis. However, the exact mechanism of its anti-inflammatory effects has yet to be fully understood.Â
Pharmacokinetics:Â
AbsorptionÂ
azelastine ophthalmic is primarily absorbed through the conjunctival blood vessels of the eye after topical administration. It rapidly penetrates the ocular tissues, allowing for local therapeutic effects.Â
DistributionÂ
After absorption, azelastine may be distributed throughout the ocular tissues, including the conjunctiva and cornea. The systemic distribution of azelastine following ocular administration is minimal, as the drug is primarily intended for local action in the eyes.Â
MetabolismÂ
azelastine undergoes hepatic metabolism primarily via the cytochrome P450 enzyme system, particularly the CYP3A4 isoenzyme. The metabolism of azelastine results in the formation of metabolites, which are then further metabolized and eventually eliminated from the body.Â
Elimination and ExcretionÂ
The exact pathway of excretion of azelastine and its metabolites following ocular administration needs to be well-documented. However, based on general principles, it is likely that the drug and its metabolites are eliminated primarily through renal excretion and potentially through fecal excretion as well.Â
Administration:Â
Ophthalmic administrationÂ
The administration of azelastine ophthalmic eye drops typically involves the following steps:Â
Patient information leafletÂ
Generic Name: azelastine ophthalmicÂ
Pronounced: [ a-ZEL-as-teen ]Â
Why do we use azelastine ophthalmic?Â
azelastine ophthalmic is primarily used to treat allergic conjunctivitis, also known as eye allergies. It is an antihistamine medication that helps to relieve symptoms associated with allergic reactions in the eyes. Some of the common uses of azelastine ophthalmic include:Â